Chapter 30. Inhibition of Cytochrome P-450 and Implications in Drug Development
- 1 January 1997
- book chapter
- Published by Elsevier
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- Structural Basis of Selective Cytochrome P450 InhibitionAnnual Review of Pharmacology and Toxicology, 1995
- Thiophene derivatives as new mechanism-based inhibitors of cytochromes P-450: Inactivation of yeast-expressed human liver cytochrome P-450 2C9 by tienilic acidBiochemistry, 1994
- Enzymatic Oxidation of Xenobiotic ChemicalCritical Reviews in Biochemistry and Molecular Biology, 1990
- POLYMORPHIC O-DEMETHYLATION OF CODEINEThe Lancet, 1988
- Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylaseBiochemistry, 1988
- Selective inhibitory interactions of alkoxymethylenedioxybenzenes towards mono-oxygenase activity in rat-hepatic microsomesXenobiotica, 1985
- Inactivation of cytochrome P‐450 and production of N‐alkylated porphyrins caused in isolated hepatocytes by substituted dihydropyridinesFEBS Letters, 1982
- A class of strong inhibitors of microsomal monooxygenases: The elupticinesChemico-Biological Interactions, 1979
- Structure-activity relationships in the effects of 1-alkylimidazoles on microsomal oxidation in vitro and in vivoBiochemical Pharmacology, 1974